Grade III Class A hospitals
A hospital-level classification covering its role, services and quality systems. It does not certify every proposed treatment.
NHC hospital assessment standard (2025) →Compare institutions by the clinical question they may help address. This selected directory connects hospital credentials with specialist strengths and documented clinical or research programmes.
An editorial guide based on public sources, not a list of RMC partner hospitals or a national ranking. Specific treatments, appointments, study recruitment and international-patient eligibility require direct institutional confirmation.
Hospital level, a national clinical role and a research designation answer different questions. Check the exact specialty and responsible institution.
A hospital-level classification covering its role, services and quality systems. It does not certify every proposed treatment.
NHC hospital assessment standard (2025) →Formally designated institutions with a national role in a defined clinical field. The exact specialty and host hospital matter.
NHC medical-centre framework →Disease-focused platforms for clinical research, collaboration and translation. Research capability is distinct from approval of a specific therapy.
National clinical research-centre framework →National Clinical Key Specialty is a separate department-level designation. A municipal clinical centre, national key discipline or hospital assessment score should retain its own title; these labels are not interchangeable.
Pancreatic, gastric and related cancer questions. Read the related patient guide →
Shanghai · 复旦大学附属肿瘤医院
Sources checked
Beijing · 北京大学肿瘤医院
The cited study concerns gastric and gastroesophageal junction cancer; it does not establish pancreatic cancer eligibility.
Sources checked
Lung, esophageal and nasopharyngeal cancer. Read the related patient guide →
Beijing · 中国医学科学院肿瘤医院
Sources checked
Guangzhou · 中山大学肿瘤防治中心
Sources checked
Leukemia, lymphoma and transplantation. Read the related patient guide →
Shanghai · 上海交通大学医学院附属瑞金医院
Sources checked
Hangzhou · 浙江大学医学院附属第一医院
Hematopoietic transplantation for blood disorders is different from unproven stem-cell treatments marketed for unrelated conditions.
Sources checked
COPD, lung fibrosis and complex lung disease. Read the related patient guide →
Beijing · 中日友好医院
Sources checked
Guangzhou · 广州医科大学附属第一医院

Thoracic surgery expertise does not mean that an operation is appropriate for every patient with COPD or lung fibrosis.
Orthopaedics, diabetes and reproductive medicine. Read the related patient guide →
Beijing · 北京大学第三医院
Arthroscopic repair is not a claim of approved stem-cell cartilage regeneration; the reproductive centre designation does not imply ovarian rejuvenation.
Sources checked
Shanghai · 上海交通大学医学院附属第六人民医院
The Shanghai diabetes clinical centre is a municipal designation. These capabilities do not establish access to stem-cell knee injections or a diabetes cure.
Sources checked
Rare diseases, multiple conditions and geriatric care. Read the related patient guide →
Beijing · 北京协和医院
Sources checked
Chengdu · 四川大学华西医院
Ageing research does not establish a proven anti-ageing or rejuvenation treatment.
Research experience is not the same as an available treatment. Published studies describe particular diseases, products and study populations. Approval, trial eligibility and present access must be checked for the exact proposal.
Institutional descriptions and centre titles are summarised from the linked official hospital, university, government or national research-platform sources. Chinese centre names are retained where useful; English translations describe those titles.
Start with the diagnosis, previous care and the question you want answered. The relevant department and proposed clinical route matter more than a hospital name alone.
Share the records you already have and any institution or treatment you want to ask about. We can clarify what requires further review.
Hospital review before travel. Case-by-case eligibility. No guaranteed outcomes.